Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Review Article Volume 5 Issue 8

Antiviral Impact of Melatonin with Reference to Influenza Virus and Covid-19 Infection

Seema Rai* and Suman Rathore

Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur, Chhattisgarh, India

*Corresponding Author: Seema Rai, Department of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur, Chhattisgarh, India.

Received: June 20, 2021; Published: July 13, 2021

Abstract

Melatonin has long been considered to play a crucial role in our interactions with viruses. Influenza, sometimes known as the flu, is an RNA virus-borne infectious illness to play a crucial role in our interactions with viruses. Influenza, sometimes known as the flu, is an RNA virus-borne infectious illness TNF-α, IL-6, and IFN-γ are inflammatory cytokines. IFN-γ inhibits the viral infection. Melatonin therapy dramatically reduces TNF-α, IL-6, and IFN-γ expression while increasing IL-10 and TGF-β production, according to this study. Melatonin promotes the synthesis of IL-10 by upregulating the expression of IL-27 in dendritic cells. Melatonin also decreases the levels of TNF-α in CD8 T cells in a considerable way. Compared to ribavirin alone, melatonin plus ribavirin co-treatment dramatically enhances the lifespan of virus-infected mice. Melatonin therapy decreases the production of inflammatory cytokines while increases the production of anti-inflammatory cytokines during influenza infection with a virus. Findings suggest that melatonin might be used as an adjuvant therapy with antiviral medications to treat influenza-induced pneumonia and COVID-19.

Keywords: COVID-19; TNF-α; Melatonin

References

  1. Zhang R., et al. “COVID-19: Melatonin as a potential adjuvant treatment”. Life Science 250 (2020): 117583.
  2. Simko F., et al. “Melatonin as a putative protection against myocardial injury in COVID-19 infection”. Taylor and Francis 13 (2020): 921-924.
  3. Tan DX., et al. “Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19”. Molecules 25 (2020): 4410.
  4. Salles C. “Correspondence COVID-19: Melatonin as a potential adjuvant treatment”. Life Sciences 253 (2020): 117716.
  5. Eccles R. “Understanding the symptoms of the common cold and influenza”. Lancet Infectious Diseases 5 (2005): 718-725.
  6. Gambotto A., et al “Human infection with highly pathogenic H5N1 influenza virus”. Lancet 371 (2008): 1464-1475.
  7. Gillim-Ross L., et al. “Emerging respiratory viruses: Challenges and vaccine strategies”. Clinical Microbiology Reviews 4 (2006): 614-636.
  8. Corral L., et al. “GLUCOCOVID: a controlled trial of methylprednisolone in adults hospitalized with COVID-10 pneumonia”. Preprint medRχiv (2020).
  9. Reiter R J., et al. “Melatonin and its metabolites: New findings regarding their production and their radical scavenging actions”. Acta Biochimica Polonica 54 (2007): 1-9.
  10. Gamboa E T., et al. “Influenza virus antigen in postencephalitic parkinsonism brain. Detection by immunofluorescence”. Archives of Neurology 31 (1974): 228-232.
  11. Pontes GN., et al. “Pineal melatonin and the innate immune response: the TNF-alpha increase after cesarean section suppresses nocturnal melatonin production”. Journal of Pineal Research 43 (2007): 365-371.
  12. Chen SJ., et al. “Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis”. International Immunopharmacology 31 (2016): 169-177.
  13. Markus RP., et al. “Immune‐pineal axis—acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes”. British Journal of Pharmacology 175 (2018): 3239‐3250.
  14. Ben-Nathan D., et al. “Protective effects of melatonin in mice infected with encephalitis viruses”. Archives of Virology 140 (1995): 223-230.
  15. Crespo I., et al. “Melatonin inhibits the sphingosine kinase 1/sphingosine-1-phosphate signaling pathway in rabbits with fulminant hepatitis of viral origin”. Journal of Pineal Research 61 (2016): 168-176.
  16. Valero N., et al. “In vitro, melatonin treatment decreases nitric oxide levels in murine splenocytes cultured with the Venezuelan equine encephalomyelitis virus”. Neurochemistry Research 30 (2005): 1439-1442.
  17. Bonilla E., et al. “Melatonin increases interleukin1β and decreases tumor necrosis factor α in the brain of mice infected with the Venezuelan equine encephalomyelitis virus”. Neurochemistry Research 28 (2003): 681-686.
  18. Sang Y., et al. “Melatonin ameliorates coxsackievirus B3-induced myocarditis by regulating apoptosis and autophagy”. Frontiers in Pharmacology 9 (2018): 1384.
  19. San-Miguel B., et al. “Melatonin modulates the autophagic response in acute liver failure induced by the rabbit hemorrhagic disease virus”. Journal of Pineal Research 56 (2014): 313-321.
  20. Montiel M., et al. “Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increases survival rate in mice infected by Venezuelan equine encephalitis virus”. Antiviral Chemistry and Chemotherapy 24 (2015): 99-108.
  21. Adikwu E., et al. “Melatonin and alpha lipoic acid restore electrolytes and kidney morphology of lopinavir/ritonavir-treated rats”. Journal of Nephropharmacology 9 (2019): e06.
  22. Cayli SR., et al. “Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury”. European Spine Journal 13 (2004): 724-732.
  23. Lin C., et al. “The involvement of a stress-activated pathway in equine influenza virus-mediated apoptosis”. Virology 287 (2001): 202-213.
  24. Fowler AA., et al. “Effect of Vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: The CITRIS-ALI randomized clinical trial”. JAMA 322 (2019): 1261-1270.
  25. Lei GS., et al. “Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia”. Antimicrobial Agents and Chemotherapy 61 (2017): e01226-1317.
  26. Fosmire GJ. “Zinc toxicity”. The American Journal of Clinical Nutrition 51 (1990): 225-227.
  27. Ghaffari H., et al. “Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: Another emerging application of nanomedicine”. Journal of Biomedical Science 26 (2019): 70.
  28. Valero N., et al. “Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis”. Brain Research 1622 (2015): 368-376.
  29. Huang S H., et al. “Melatonin possesses an anti-influenza potential through its immune modulatory effect”. Journal of Functional Foods 58 (2019): 189-198.
  30. Rabbani MAG., et al. “5-Hydroxytryptophan, a major product of tryptophan degradation, is essential for optimal replication of human parainfluenza virus”. Virology 503 (2017): 46-51.
  31. Junaid A., et al. “Ebola hemorrhagic shock syndrome-on-a-chip”. iScience 23 (2020): 100765.
  32. Lai KY., et al. “High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia”. Annals of Internal Medicine 152 (2010): 687-688.
  33. Kimbarowski JA., et al. “Colored precipitation reaction of the urine according to Kimbarowski (FARK) as an index of the effect of ascorbic acid during treatment of viral influenza”. Dtsch Gesundheitsw 22 (1967): 2413-2418.
  34. Zhao Y., et al. “Vitamin D Alleviates Rotavirus Infection through a Microrna-155-5p Mediated Regulation of the TBK1/IRF3 Signaling Pathway In Vivo and In Vitro”. International Journal of Molecular Sciences 20 (2019): 3562.
  35. Al-Taie A., et al. “Potential Therapeutic Use of Coenzyme Q10 in Diabetes Mellitus and Its Complications: an Algorithm of Scoping Clinical Review”. SN Comprehensive Clinical Medicine 3 (2021): 989-1001.
  36. Wong CK., et al. “Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome”. Clinical and Experimental Immunology 136 (2004): 95-103.
  37. Cardinali DP., et al. “Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration”. Sleep and Vigilance 4 (2020): 81-87.
  38. Nunes Oda S. “Regression of herpes viral infection symptoms using melatonin and SB-73: comparison with Acyclovir”. Journal of Pineal Research 44 (2008): 373-378.
  39. Mistraletti G., et al. “Melatonin reduces the need for sedation in ICU patients: a randomized controlled trial”. Minerva Anaesthesiology 81 (2015): 1298-1310.
  40. Bourne RS., et al. “Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial”. Critical Care (London, England) 12 (2008): R52.
  41. Fitzgerald DC., et al. “Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells”. Nature Immunology 8 (2007): 1372-1379.
  42. Sidwell RW., et al. “Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide”. Science 177 (1972): 705-706.

Citation

Citation: Seema Rai and Suman Rathore. “Antiviral Impact of Melatonin with Reference to Influenza Virus and Covid-19 Infection”. Acta Scientific Cancer Biology 5.8 (2021): 37-42.

Copyright

Copyright: © 2021 Seema Rai and Suman Rathore. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.018

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 05, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US